Australia markets closed

AEON Biopharma, Inc. (AEON)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.5500+0.1600 (+11.51%)
At close: 04:00PM EDT
1.4200 -0.13 (-8.39%)
Pre-market: 07:35AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
5,158
9,746
5,128
20,168
-
Other short-term investments
-
-
-
0
105,421
Total cash
5,158
9,746
5,128
20,168
-
Net receivables
-
-
-
0
267
Other current assets
1,064
92
26
208
-
Total current assets
6,222
9,838
5,154
20,376
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
764
977
925
-
-
Accumulated depreciation
-170
-71
-3
-
-
Net property, plant and equipment
594
906
922
-
-
Equity and other investments
-
-
-
0
1,429
Other long-term assets
29
34
360
838
-
Total non-current assets
623
940
1,282
838
-
Total assets
6,845
10,778
6,436
21,214
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
70,866
15,603
-
14,790
Accounts payable
3,388
7,805
1,192
2,031
-
Accrued liabilities
7,871
2,534
2,943
914
-
Total current liabilities
13,049
82,574
20,804
4,197
-
Non-current liabilities
Long-term debt
-
60,426
70,762
72,160
15,161
Other long-term liabilities
104,350
-
221
10,142
9,616
Total non-current liabilities
146,840
198,617
209,456
220,251
-
Total liabilities
159,889
281,191
230,260
224,448
-
Stockholders' equity
Common stock
4
14
14
11
-
Retained earnings
-473,602
-474,839
-422,283
-366,646
-
Total stockholders' equity
-153,044
-287,500
-234,944
-208,273
-
Total liabilities and stockholders' equity
6,845
10,778
6,436
21,214
-